GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (OTCPK:OPORF) » Definitions » Change In Other Working Capital

hVIVO (OPORF) Change In Other Working Capital : $-6.43 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is hVIVO Change In Other Working Capital?

hVIVO's Change In Other Working Capital for the quarter that ended in Dec. 2024 was $-6.04 Mil. It means hVIVO's Other Working Capital declined by $6.04 Mil from Jun. 2024 to Dec. 2024 .

hVIVO's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was $-6.42 Mil. It means hVIVO's Other Working Capital declined by $6.42 Mil from Dec. 2023 to Dec. 2024 .


hVIVO Change In Other Working Capital Historical Data

The historical data trend for hVIVO's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

hVIVO Change In Other Working Capital Chart

hVIVO Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.37 -3.95 13.58 6.76 -6.42

hVIVO Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.09 -0.97 7.73 -0.39 -6.04

hVIVO Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-6.43 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


hVIVO Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of hVIVO's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


hVIVO Business Description

Industry
Traded in Other Exchanges
Address
40 Bank Street, Floor 24, London, GBR, E14 5NR
hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which is involved in the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

hVIVO Headlines

From GuruFocus

Half Year 2024 hVIVO PLC Investor Presentation Transcript

By GuruFocus Research 09-11-2024

Full Year 2023 hVIVO PLC Analyst Briefing Transcript

By GuruFocus Research 04-12-2024

Half Year 2023 hVIVO PLC Earnings Call Transcript

By GuruFocus Research 02-14-2024